Dr. MartensDRMTY 73 Days Payable is 102.19 as of Mar. 2026, which is 132% above its 10-year median of 44.00. GuruFocus rates DRMTY with a GF Score™ of 73/100 and a GF Value™ of $1.89 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,020 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 72.35% on this metric.
Dr. Martens's Days Payable
increased
from Mar. 2025 (93.63) to Mar. 2026 (102.19).
It may suggest that Dr. Martensdelayed paying its suppliers.
Dr. Martens Days Payable Related Terms
Dr. Martens Days Payable Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Footwear & Accessories subindustry, Dr. Martens's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Days Payable vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Days Payable distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Dr. Martens's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (DRMTY) has a Days Payable of 102.19 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dr. Martens and its competitors. This is 132% above median its historical median of 44.00. Over the past decade, Dr. Martens' Days Payable has ranged from 36.00 to 89.57. According to the industry distribution chart, Dr. Martens ranks #282 out of 1020 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 27.6%.
Is Dr. Martens' Days Payable too high?
Dr. Martens' current Days Payable of 102.19 is 132% above median its 10-year median of 44.00. Over the past 10 years, this metric has ranged from a low of 36.00 to a high of 89.57. The Manufacturing - Apparel & Accessories industry median Days Payable is 54.14. Dr. Martens' value of 102.19 is 88.8% above this industry median. Based on the distribution chart, Dr. Martens ranks #282 out of 1020 companies in the Manufacturing - Apparel & Accessories industry, which is above the industry midpoint. Overall, Dr. Martens has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Days Payable compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #282 out of 1020 companies for Days Payable. This puts Dr. Martens in the upper half of its industry. The industry median Days Payable is 54.14. Dr. Martens' value of 102.19 is 88.8% above this benchmark. Historically, Dr. Martens' own Days Payable has ranged from 36.00 to 89.57 over the past decade. While the company's 10-year median is 44.00 vs. the industry median of 54.14, Dr. Martens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Manufacturing - Apparel & Accessories company?
The median Days Payable among Manufacturing - Apparel & Accessories companies is 54.14, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Days Payable of 102.19 is 88.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Days Payable is 54.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Days Payable is 102.19, which is 132% above median its own 10-year median of 44.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DRMTY) is currently considered Fairly Valued. The stock's GF Value™ is $1.89, compared to a current price of $1.83 — trading 3.2% below its estimated fair value. The current Days Payable is 102.19, which is 132% above median its 10-year median of 44.00 and 88.8% above the Manufacturing - Apparel & Accessories industry median of 54.14. Dr. Martens' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dr. Martens (DRMTY), the current Days Payable is 102.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DRMTY) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $1.83 is trading 3.2% below its estimated GF Value™ of $1.89.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DRMTY:
Days Payable: 102.19 (132% above median its 10-year median of 44.00)
GF Value™: $1.89 vs. price of $1.83 (3.2% below fair value)
Industry Position: 88.8% above the Manufacturing - Apparel & Accessories median (#282 of 1020)
No single metric tells the full story. See the DRMTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
73GF Score
Get the complete analysis for DRMTY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRMTY has been successfully added to your 
